Crizanlizumab, CAS 1690318-25-2

Description: Crizanlizumab (Adakveo) is a humanized monoclonal antibody against P-selectin for the prevention of pain crises in sickle cell disease.

CAS Number: 1690318-25-2

References: Hannah A. Blair, et al. Crizanlizumab: First Approval. Drugs. 80, 79-84 (2020).

• Artikelnummer: TGMT77399-10mg
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: T77399-10mg
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK